company background image
EVROF logo

Evrofarma ATSE:EVROF Stock Report

Last Price

€1.68

Market Cap

€23.0m

7D

8.4%

1Y

102.4%

Updated

25 Apr, 2024

Data

Company Financials

Evrofarma SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Evrofarma
Historical stock prices
Current Share Price€1.68
52 Week High€1.94
52 Week Low€0.75
Beta1.18
1 Month Change-6.67%
3 Month Change23.53%
1 Year Change102.41%
3 Year Change61.54%
5 Year Change105.38%
Change since IPO-67.80%

Recent News & Updates

Subdued Growth No Barrier To Evrofarma SA (ATH:EVROF) With Shares Advancing 30%

Feb 29
Subdued Growth No Barrier To Evrofarma SA (ATH:EVROF) With Shares Advancing 30%

Evrofarma SA (ATH:EVROF) Stock Rockets 33% But Many Are Still Ignoring The Company

Jan 06
Evrofarma SA (ATH:EVROF) Stock Rockets 33% But Many Are Still Ignoring The Company

Recent updates

Subdued Growth No Barrier To Evrofarma SA (ATH:EVROF) With Shares Advancing 30%

Feb 29
Subdued Growth No Barrier To Evrofarma SA (ATH:EVROF) With Shares Advancing 30%

Evrofarma SA (ATH:EVROF) Stock Rockets 33% But Many Are Still Ignoring The Company

Jan 06
Evrofarma SA (ATH:EVROF) Stock Rockets 33% But Many Are Still Ignoring The Company

Returns On Capital At Evrofarma (ATH:EVROF) Have Stalled

Jan 05
Returns On Capital At Evrofarma (ATH:EVROF) Have Stalled

Evrofarma (ATH:EVROF) Has A Somewhat Strained Balance Sheet

Dec 01
Evrofarma (ATH:EVROF) Has A Somewhat Strained Balance Sheet

Here's What's Concerning About Evrofarma's (ATH:EVROF) Returns On Capital

Sep 15
Here's What's Concerning About Evrofarma's (ATH:EVROF) Returns On Capital

Is Evrofarma (ATH:EVROF) Using Too Much Debt?

May 27
Is Evrofarma (ATH:EVROF) Using Too Much Debt?

We Think That There Are Issues Underlying Evrofarma's (ATH:EVROF) Earnings

Oct 04
We Think That There Are Issues Underlying Evrofarma's (ATH:EVROF) Earnings

Returns On Capital At Evrofarma (ATH:EVROF) Paint A Concerning Picture

May 19
Returns On Capital At Evrofarma (ATH:EVROF) Paint A Concerning Picture

Should Evrofarma SA (ATH:EVROF) Focus On Improving This Fundamental Metric?

Feb 22
Should Evrofarma SA (ATH:EVROF) Focus On Improving This Fundamental Metric?

Be Wary Of Evrofarma (ATH:EVROF) And Its Returns On Capital

Dec 29
Be Wary Of Evrofarma (ATH:EVROF) And Its Returns On Capital

Is Evrofarma SA's (ATH:EVROF) 2.2% ROE Worse Than Average?

Nov 22
Is Evrofarma SA's (ATH:EVROF) 2.2% ROE Worse Than Average?

Shareholder Returns

EVROFGR FoodGR Market
7D8.4%-2.8%3.7%
1Y102.4%55.2%28.5%

Return vs Industry: EVROF exceeded the Greek Food industry which returned 59.1% over the past year.

Return vs Market: EVROF exceeded the Greek Market which returned 29.7% over the past year.

Price Volatility

Is EVROF's price volatile compared to industry and market?
EVROF volatility
EVROF Average Weekly Movement7.6%
Food Industry Average Movement4.0%
Market Average Movement4.1%
10% most volatile stocks in GR Market8.0%
10% least volatile stocks in GR Market2.4%

Stable Share Price: EVROF has not had significant price volatility in the past 3 months.

Volatility Over Time: EVROF's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Greek stocks.

About the Company

FoundedEmployeesCEOWebsite
1991157Paschalis Papazilakiswww.evrofarma.gr

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products.

Evrofarma SA Fundamentals Summary

How do Evrofarma's earnings and revenue compare to its market cap?
EVROF fundamental statistics
Market cap€22.97m
Earnings (TTM)€2.86m
Revenue (TTM)€49.25m

8.0x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EVROF income statement (TTM)
Revenue€49.25m
Cost of Revenue€41.03m
Gross Profit€8.22m
Other Expenses€5.36m
Earnings€2.86m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.21
Gross Margin16.69%
Net Profit Margin5.80%
Debt/Equity Ratio148.3%

How did EVROF perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.